# OnCo record paper-cupisco-molecularly-guided-therapy-cup-lancet-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cupisco-molecularly-guided-therapy-cup-lancet-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cupisco-molecularly-guided-therapy-cup-lancet-2024" ;
  schema:name "CUPISCO: molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary"@en ;
  schema:description "In the first large randomised trial in cancer of unknown primary, choosing a targeted drug or immunotherapy from the tumour's genomic profile after three cycles of chemotherapy held the disease back for longer than simply continuing chemotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-cupisco-molecularly-guided-therapy-cup-lancet-2024/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(24)00814-6>, <https://pubmed.ncbi.nlm.nih.gov/39096924/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(24)00814-6> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Krämer A, Bochtler T, Pauli C, et al." ;
  onco:cancers <https://onco.cc/cancers/cup-unfavourable/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/gemcitabine-cisplatin/> ;
  onco:trials <https://onco.cc/trials/cupisco/> ;
  onco:journals <https://onco.cc/journals/lancet/> .